T1	DISO 74 85	albuminuria
#1	AnnotatorNotes T1	C0001925; Albuminuria; Finding
T2	PROC 88 105	control glucémico
#2	AnnotatorNotes T2	C3669205; Blood glucose monitoring (regime/therapy); Therapeutic or Preventive Procedure | C5392125; Glycemic Control; Therapeutic or Preventive Procedure | C3267174; Glycaemia control; Therapeutic or Preventive Procedure
T3	DISO 123 150	nefropatía diabética tipo 2
#3	AnnotatorNotes T3	C0011881; Diabetic Nephropathy; Disease or Syndrome (?)
T4	PROC 155 175	estudio aleatorizado
#4	AnnotatorNotes T4	C0206034; Clinical Trials, Randomized; Research Activity
T5	DISO 191 208	diabéticos tipo 2
#5	AnnotatorNotes T5	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T6	DISO 213 224	albuminuria
#6	AnnotatorNotes T6	C0001925; Albuminuria; Finding
T7	DISO 256 287	complicaciones cardiovasculares
#7	AnnotatorNotes T7	C0161816; Cardiac complication; Pathologic Function
T8	PROC 300 328	tratamiento antihipertensivo
#8	AnnotatorNotes T8	C0585941; Antihypertensive therapy; Therapeutic or Preventive Procedure
T9	PROC 1067 1083	presión arterial
#9	AnnotatorNotes T9	C0005824; Blood pressure determination; Health Care Activity
T10	CHEM 513 519	renina
#10	AnnotatorNotes T10	C0035094; Renin; Amino Acid, Peptide, or Protein · Enzyme
T11	CHEM 520 532	angiotensina
#11	AnnotatorNotes T11	C0003018; Angiotensins; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T12	PROC 56 72	presión arterial
#12	AnnotatorNotes T12	C0005824; Blood pressure determination; Health Care Activity
T13	DISO 547 558	albuminuria
#13	AnnotatorNotes T13	C0001925; Albuminuria; Finding
T14	PROC 561 578	control glucémico
#14	AnnotatorNotes T14	C3669205; Blood glucose monitoring (regime/therapy); Therapeutic or Preventive Procedure | C5392125; Glycemic Control; Therapeutic or Preventive Procedure | C3267174; Glycaemia control; Therapeutic or Preventive Procedure
T15	PROC 543 545	PA
#15	AnnotatorNotes T15	C0005824; Blood pressure determination; Health Care Activity
T16	DISO 737 754	diabéticos tipo 2
#16	AnnotatorNotes T16	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T17	DISO 759 770	albuminuria
#17	AnnotatorNotes T17	C0001925; Albuminuria; Finding
T18	CHEM 890 902	verapamil SR
#18	AnnotatorNotes T18	C1527129; Verapamil SR; Organic Chemical · Pharmacologic Substance
T19	CHEM 903 915	trandolapril
#19	AnnotatorNotes T19	C0076891; trandolapril; Organic Chemical · Pharmacologic Substance
T20	CHEM 929 937	losartan
#20	AnnotatorNotes T20	C0126174; losartan; Organic Chemical · Pharmacologic Substance
T21	CHEM 938 955	hidroclorotiazida
#21	AnnotatorNotes T21	C0020261; hydrochlorothiazide; Organic Chemical · Pharmacologic Substance
T22	PROC 993 1004	tratamiento
#22	AnnotatorNotes T22	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T23	ANAT 1095 1103	urinaria
#23	AnnotatorNotes T23	C0042036; Urine; Body Substance
T24	CHEM 1107 1115	albúmina
#24	AnnotatorNotes T24	C0001924; Albumins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T25	PROC 1128 1151	hemoglobina glicosilada
#25	AnnotatorNotes T25	C0202054; Glucohemoglobin measurement; Laboratory Procedure
T26	CHEM 1154 1158	urea
#26	AnnotatorNotes T26	C0041942; urea; Biologically Active Substance · Organic Chemical · Pharmacologic Substance
T27	ANAT 1159 1169	plasmática
#27	AnnotatorNotes T27	C0032105; Plasma; Body Substance
T28	PROC 1174 1176	PA
#28	AnnotatorNotes T28	C0005824; Blood pressure determination; Health Care Activity
T29	PROC 1299 1311	tratamientos
#29	AnnotatorNotes T29	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T30	DISO 1513 1524	albuminuria
#30	AnnotatorNotes T30	C0001925; Albuminuria; Finding
T31	PROC 1659 1671	tratamientos
#31	AnnotatorNotes T31	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T32	PROC 1676 1699	hemoglobina glicosilada
#32	AnnotatorNotes T32	C0202054; Glucohemoglobin measurement; Laboratory Procedure
T33	PROC 1919 1931	tratamientos
#33	AnnotatorNotes T33	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T34	CHEM 1948 1952	urea
#34	AnnotatorNotes T34	C0041942; urea; Biologically Active Substance · Organic Chemical · Pharmacologic Substance
T35	ANAT 1953 1963	plasmática
#35	AnnotatorNotes T35	C0032105; Plasma; Body Substance
T36	DISO 2131 2148	diabéticos tipo 2
#36	AnnotatorNotes T36	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T37	DISO 2153 2164	albuminuria
#37	AnnotatorNotes T37	C0001925; Albuminuria; Finding
T38	PROC 2180 2192	tratamientos
#38	AnnotatorNotes T38	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T39	PROC 2204 2220	presión arterial
#39	AnnotatorNotes T39	C0005824; Blood pressure determination; Health Care Activity
T40	DISO 2226 2237	albuminuria
#40	AnnotatorNotes T40	C0001925; Albuminuria; Finding
T41	CHEM 2271 2280	verapamil
#41	AnnotatorNotes T41	C0042523; verapamil; Organic Chemical · Pharmacologic Substance
T42	CHEM 2281 2293	trandolapril
#42	AnnotatorNotes T42	C0076891; trandolapril; Organic Chemical · Pharmacologic Substance
T43	CHEM 2333 2347	hidrocarbonado
#43	AnnotatorNotes T43	C0020242; Hydrocarbons; Organic Chemical
T44	CHEM 2352 2360	losartan
#44	AnnotatorNotes T44	C0126174; losartan; Organic Chemical · Pharmacologic Substance
T45	CHEM 2361 2378	hidroclorotiazida
#45	AnnotatorNotes T45	C0020261; hydrochlorothiazide; Organic Chemical · Pharmacologic Substance
T46	ANAT 64 72	arterial
#46	AnnotatorNotes T46	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T47	ANAT 271 287	cardiovasculares
#47	AnnotatorNotes T47	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T48	CHEM 312 328	antihipertensivo
#48	AnnotatorNotes T48	C0003364; Antihypertensive Agents; Pharmacologic Substance
T49	ANAT 505 532	sistema renina-angiotensina
#49	AnnotatorNotes T49	C0035096; Renin-angiotensin system; Body System
T50	PROC 583 651	diseño fue prospectivo, aleatorizado, de ramas paralelas, controlado
#50	AnnotatorNotes T50	C2826345; Parallel Study; Research Activity + C0033522; Prospective Studies; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity
T51	PROC 874 887	aleatorizados
#51	AnnotatorNotes T51	C0034656; Randomization; Research Activity
T52	ANAT 1075 1083	arterial
#52	AnnotatorNotes T52	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T53	PROC 1085 1115	excreción urinaria de albúmina
#53	AnnotatorNotes T53	C0585937; Albumin excretion rate measurement; Laboratory Procedure
T54	PROC 1154 1169	urea plasmática
#54	AnnotatorNotes T54	C0856667; Plasma urea; Laboratory Procedure
T55	PROC 1948 1963	urea plasmática
#55	AnnotatorNotes T55	C0856667; Plasma urea; Laboratory Procedure
T56	ANAT 2212 2220	arterial
#56	AnnotatorNotes T56	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T57	CHEM 29 46	antihipertensivas
#57	AnnotatorNotes T57	C0003364; Antihypertensive Agents; Pharmacologic Substance
T59	LIVB 109 118	pacientes
#58	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	LIVB 181 190	pacientes
#59	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	Spec_cue 246 255	riesgo de
T65	Duration 840 851	dos semanas
T66	LIVB 857 866	pacientes
#60	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T67	Date 823 836	pre-inclusión
T68	Duration 1009 1015	un año
T70	PHYS 1085 1103	excreción urinaria
#61	AnnotatorNotes T70	C0042034; Urination; Organism Function | C2371165; Urination functions; Organ or Tissue Function
T71	Duration 1117 1125	24 horas
T82	LIVB 2121 2130	pacientes
#62	AnnotatorNotes T82	C0030705; Patients; Patient or Disabled Group
T87	PHYS 2314 2332	control metabólico
#63	AnnotatorNotes T87	C1513158; Metabolic Control; Molecular Function
A1	Assertion T7 Speculated
T58	Neg_cue 1622 1625	sin
T62	CONC 1626 1637	diferencias
A2	Assertion T62 Negated
#64	AnnotatorNotes T62	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T58 Arg2:T62	
T63	Frequency 971 975	/día
T64	Dose 961 963	20
T69	Dose 964 971	12,5 mg
T72	Dose 916 919	180
T73	Dose 920 921	2
#65	AnnotatorNotes T72	[Dose expressed in milligrammes]
#66	AnnotatorNotes T73	[Dose expressed in milligrammes]
#67	AnnotatorNotes T64	[Dose expressed in milligrammes]
R2	Location_of Arg1:T46 Arg2:T12	
R3	Experiences Arg1:T59 Arg2:T3	
R4	Experiences Arg1:T59 Arg2:T2	
R5	Experiences Arg1:T59 Arg2:T1	
R6	Speculation Arg1:T61 Arg2:T7	
R7	Location_of Arg1:T47 Arg2:T7	
R8	Experiences Arg1:T59 Arg2:T12	
T74	Observation 1 7	Efecto
#68	AnnotatorNotes T74	C1518681; Outcome of Therapy; Finding (?)
R9	Causes Arg1:T57 Arg2:T74	
R10	Experiences Arg1:T59 Arg2:T57	
R11	Overlap Arg1:T1 Arg2:T3	
R12	Experiences Arg1:T60 Arg2:T5	
R13	Overlap Arg1:T5 Arg2:T6	
R14	Experiences Arg1:T60 Arg2:T7	
R15	Before Arg1:T6 Arg2:T7	
R16	Before Arg1:T5 Arg2:T7	
T75	Observation 238 255	elevado riesgo de
#69	AnnotatorNotes T75	C0332167; High risk of; Finding
R18	Experiences Arg1:T60 Arg2:T8	
R19	Used_for Arg1:T48 Arg2:T8	
T76	Observation 439 445	efecto
#70	AnnotatorNotes T76	C1518681; Outcome of Therapy; Finding (?)
R20	Overlap Arg1:T16 Arg2:T17	
T77	Quantifier_or_Qualifier 771 778	estable
#71	AnnotatorNotes T77	C0205360; Stable status; Qualitative Concept
R21	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T77	
T78	CONC 812 836	período de pre-inclusión
R22	Has_Duration_or_Interval Arg1:T78 Arg2:T65	
R23	Experiences Arg1:T66 Arg2:T18	
R24	Has_Dose_or_Strength Arg1:T19 Arg2:T73	
R25	Has_Dose_or_Strength Arg1:T18 Arg2:T72	
R26	Combined_with Arg1:T18 Arg2:T19	
R27	Combined_with Arg1:T20 Arg2:T21	
R28	Has_Dose_or_Strength Arg1:T20 Arg2:T64	
R29	Has_Dose_or_Strength Arg1:T21 Arg2:T69	
R30	Has_Frequency Arg1:T21 Arg2:T63	
R31	Has_Frequency Arg1:T20 Arg2:T63	
R32	Has_Frequency Arg1:T19 Arg2:T63	
R33	Has_Frequency Arg1:T18 Arg2:T63	
R34	Experiences Arg1:T66 Arg2:T20	
R35	Before Arg1:T51 Arg2:T18	
R36	Before Arg1:T51 Arg2:T20	
R37	Has_Duration_or_Interval Arg1:T22 Arg2:T68	
R38	Location_of Arg1:T52 Arg2:T9	
R40	Overlap Arg1:T53 Arg2:T71	
R41	Location_of Arg1:T27 Arg2:T54	
T79	Quantifier_or_Qualifier 1177 1183	global
#72	AnnotatorNotes T79	C2348867; Global; Qualitative Concept
R42	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T79	
T80	Observation 1174 1176;1184 1193	PA descendió
T81	CONC 1374 1381	inicial
#73	AnnotatorNotes T81	C0205265; Initially; Temporal Concept
T83	CONC 1461 1468	inicial
#74	AnnotatorNotes T83	C0205265; Initially; Temporal Concept
T84	CONC 1415 1420	final
#75	AnnotatorNotes T84	C3853528; Final; Temporal Concept
T85	CONC 1503 1508	final
#76	AnnotatorNotes T85	C3853528; Final; Temporal Concept
T86	Observation 1513 1534	albuminuria se redujo
R43	Causes Arg1:T31 Arg2:T86	
T88	Observation 1676 1709	hemoglobina glicosilada descendió
#77	AnnotatorNotes T88	C0855304; Glycosylated haemoglobin decreased; Finding
T89	CONC 1805 1810	ANOVA
#78	AnnotatorNotes T89	C0002780; Analysis of Variance; Quantitative Concept
T90	CONC 2084 2089	ANOVA
#79	AnnotatorNotes T90	C0002780; Analysis of Variance; Quantitative Concept
T91	CONC 1854 1869	valores basales
#80	AnnotatorNotes T91	C1442488; Baseline; Quantitative Concept
R44	Location_of Arg1:T35 Arg2:T55	
R45	Overlap Arg1:T36 Arg2:T37	
R46	Experiences Arg1:T82 Arg2:T36	
R47	Experiences Arg1:T82 Arg2:T37	
R48	Location_of Arg1:T56 Arg2:T39	
T93	Observation 2193 2220	reducen la presión arterial
R49	Causes Arg1:T38 Arg2:T93	
T94	Observation 2193 2200;2223 2237	reducen la albuminuria
R50	Causes Arg1:T38 Arg2:T94	
R51	Experiences Arg1:T82 Arg2:T38	
R52	Experiences Arg1:T82 Arg2:T94	
R53	Experiences Arg1:T82 Arg2:T39	
R54	Experiences Arg1:T82 Arg2:T93	
R55	Combined_with Arg1:T41 Arg2:T42	
R56	Causes Arg1:T41 Arg2:T87	
R57	Combined_with Arg1:T44 Arg2:T45	
R58	Causes Arg1:T44 Arg2:T87	
R59	Has_Quantifier_or_Qualifier Arg1:T87 Arg2:T43	
R17	Before Arg1:T75 Arg2:T7	
R60	Overlap Arg1:T6 Arg2:T75	
R61	Experiences Arg1:T60 Arg2:T75	
R62	Overlap Arg1:T5 Arg2:T75	
R39	Experiences Arg1:T82 Arg2:T40	
R63	Location_of Arg1:T23 Arg2:T53	
A3	Experiencer T59 Patient
A4	Experiencer T60 Patient
A5	Experiencer T66 Patient
A6	Experiencer T82 Patient
R64	Has_Result_or_Value Arg1:T28 Arg2:T80	
R65	Has_Result_or_Value Arg1:T32 Arg2:T88	
R66	Has_Result_or_Value Arg1:T39 Arg2:T93	
